Risk and Association
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
Understanding risk and association is fundamental in biostatistics, especially in epidemiology
and public health. These concepts help determine how strongly a particular exposure (like
smoking) is linked to a specific outcome (like lung cancer). The main tools used are relative risk
(RR) and odds ratio (OR), which are both measures of association.
Relative risk compares the probability of an event occurring in the exposed group with the
probability in the unexposed group. It's intuitive: if RR = 2.0, the exposed group is twice as
likely to experience the outcome. However, this measure is mostly valid in cohort studies,
where people are followed over time.
Odds ratio, on the other hand, compares the odds of an event in two groups. It's the go-to
measure in case-control studies, where we work backward from outcomes to exposures. While
OR can approximate RR when the event is rare, it often overestimates the effect when the
outcome is common.
We also looked into attributable risk, which calculates the actual difference in risk between
exposed and unexposed groups. This is useful when we want to express how much of the risk is
due to the exposure itself, not just how strong the association is.
One challenge I found in class was distinguishing when to use RR versus OR. The key is
understanding the study design: cohort = RR, case-control = OR. But in practice, papers often
report OR even in scenarios where RR might make more sense, probably because logistic
regression (which uses OR) is commonly used for binary outcomes.
Another concept discussed was confounding, where an external factor distorts the true
relationship between exposure and outcome. For example, if age is linked to both coffee drinking
and heart disease, it could confound the relationship between the two. The goal is to control for
confounders using stratification or regression models.
Effect modification was also introduced. Unlike confounding, effect modification is a real
interaction – it means the strength of the association changes across levels of another variable. A
classic example is aspirin reducing heart attacks more effectively in men than in women.
What I found especially useful was the real-world application: being able to interpret risk ratios
in medical journals and knowing what they actually mean in context. Just seeing "RR = 3.0" isn’t
enough – we also need to ask, “Is this statistically significant? Is it clinically meaningful?”
Reflection:
This topic made me realize how easy it is to misinterpret numbers if we’re not careful. A risk
ratio sounds dramatic, but without understanding the baseline risk, the impact could be
overstated. I now look at health stats with a more skeptical eye and always ask: Compared to
what? The session helped sharpen not just my statistical thinking, but also my judgment in
evaluating health claims. Biostatistics is more than math – it’s about making sense of human
data.
